|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Cash | |||||
| Assets | |||||
| Investment in solana, at fair value (cost $26,613,233, and $28,300,073, respectively) | |||||
| Receivable for investment in solana sold | |||||
| Total assets | |||||
| Liabilities | |||||
| Payable for shares redeemed | |||||
| Accrued Sponsor fee | |||||
| Total liabilities | |||||
| Commitments and contingent liabilities (Note 6) | |||||
| Net assets | |||||
| Shares issued (in Shares) | |||||
| Shares outstanding (in Shares) | |||||
| Net Asset Value per Share (in Dollars per share) |
Loading...